CH645890A5 - Monacolin k, seine herstellung und dieses enthaltendes antihypercholesterinaemisches mittel. - Google Patents
Monacolin k, seine herstellung und dieses enthaltendes antihypercholesterinaemisches mittel. Download PDFInfo
- Publication number
- CH645890A5 CH645890A5 CH136680A CH136680A CH645890A5 CH 645890 A5 CH645890 A5 CH 645890A5 CH 136680 A CH136680 A CH 136680A CH 136680 A CH136680 A CH 136680A CH 645890 A5 CH645890 A5 CH 645890A5
- Authority
- CH
- Switzerland
- Prior art keywords
- monacolin
- strain
- microorganism
- production
- monascus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Obesity (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54017856A JPS5925599B2 (ja) | 1979-02-20 | 1979-02-20 | 新生理活性物質モナコリンkおよびその製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH645890A5 true CH645890A5 (de) | 1984-10-31 |
Family
ID=11955290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH136680A CH645890A5 (de) | 1979-02-20 | 1980-02-20 | Monacolin k, seine herstellung und dieses enthaltendes antihypercholesterinaemisches mittel. |
Country Status (27)
Country | Link |
---|---|
JP (1) | JPS5925599B2 (fr) |
KR (1) | KR830002801B1 (fr) |
AT (1) | AT373915B (fr) |
AU (1) | AU532626B2 (fr) |
BE (1) | BE881825A (fr) |
CA (1) | CA1129794A (fr) |
CH (1) | CH645890A5 (fr) |
DD (1) | DD154494A5 (fr) |
DE (2) | DE3051175C2 (fr) |
DK (2) | DK149095C (fr) |
ES (1) | ES8103171A1 (fr) |
FI (1) | FI66427C (fr) |
FR (1) | FR2449685B1 (fr) |
GB (1) | GB2046737B (fr) |
HU (1) | HU182069B (fr) |
IE (1) | IE49743B1 (fr) |
IT (1) | IT1175260B (fr) |
MX (1) | MX6314E (fr) |
NL (1) | NL191540C (fr) |
NO (1) | NO153974C (fr) |
NZ (1) | NZ192919A (fr) |
PH (1) | PH15145A (fr) |
PL (1) | PL124304B1 (fr) |
SE (1) | SE453301B (fr) |
SG (1) | SG6784G (fr) |
SU (2) | SU1158048A3 (fr) |
ZA (1) | ZA80962B (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55150898A (en) * | 1979-05-11 | 1980-11-25 | Sankyo Co Ltd | Preparation of a new physiologically active substance mb-530b |
US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
JPS5621594A (en) * | 1979-07-27 | 1981-02-28 | Sankyo Co Ltd | Mb-530b carboxylic acid metal salt and its preparation |
PT72394B (en) * | 1980-02-04 | 1982-09-06 | Merck & Co Inc | Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics |
AU548996B2 (en) * | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
JPH0692381B2 (ja) * | 1980-03-31 | 1994-11-16 | 三共株式会社 | Mb−530a誘導体 |
JPS56142236A (en) | 1980-04-08 | 1981-11-06 | Sankyo Co Ltd | Ml-236a and mb-530a derivative |
DK149080C (da) * | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
JPS5835144A (ja) * | 1981-08-27 | 1983-03-01 | Sankyo Co Ltd | Mb−530b誘導体およびその製造法 |
US4782084A (en) * | 1987-06-29 | 1988-11-01 | Merck & Co., Inc. | HMG-COA reductase inhibitors |
US4997848A (en) * | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
CA2062023A1 (fr) * | 1992-02-10 | 1993-08-11 | Jagroop S. Dahiya | Nouvelles souches fongiques et leur utilisation pour la production d'antibiotiques |
JPH07504568A (ja) * | 1992-03-04 | 1995-05-25 | 藤沢薬品工業株式会社 | HMG−CoAレダクターゼ阻害物質としてのテトラリン誘導体 |
NZ247617A (en) | 1992-05-15 | 1995-07-26 | Sankyo Co | Octahydronaphthalene oxime derivatives and pharmaceutical compositions |
US6812007B1 (en) * | 1992-11-04 | 2004-11-02 | Keri Vilmos | Process for the isolation and purification of mevinolin |
HU210867B (en) * | 1992-11-04 | 1995-10-30 | Biogal Gyogyszergyar | Method for extraction and purification of mevinolin from culture medium |
SI9300303A (en) * | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
US5409820A (en) * | 1993-08-06 | 1995-04-25 | Apotex, Inc. | Process for the production of lovastatin using Coniothyrium fuckelii |
US6046022A (en) | 1996-09-30 | 2000-04-04 | Peking University | Methods and compositions employing red rice fermentation products |
US7238348B2 (en) | 1996-09-30 | 2007-07-03 | Beijing Peking University Wbl Corporation Ltd. | Method of treatment of osteoporosis with compositions of red rice fermentation products |
NZ500870A (en) | 1998-03-20 | 2002-03-01 | Biogal Gyogyszergyar | Metabolic controlled fermentation process for preparing mevinolin (lovastatin) |
AU3654301A (en) | 2000-02-24 | 2001-09-03 | Biogal Gyogyszergyar | Method of purifying a fermentation broth |
HUP0301214A2 (hu) | 2000-03-03 | 2003-08-28 | Plus Chemicals S.A. | Tisztítási eljárás csökkentett dimer szennyező tartalmú lovastatin és simvastatin előállítására |
KR20010095780A (ko) * | 2000-04-12 | 2001-11-07 | 나가오카 마사시 | 배아 홍국 |
IN192861B (fr) | 2000-06-30 | 2004-05-22 | Ranbaxy Lab Ltd | |
WO2002064809A2 (fr) * | 2001-02-09 | 2002-08-22 | Unilever N.V. | Methode de preparation d'une ou plusieurs statines par fermentation |
KR100379075B1 (en) | 2002-03-07 | 2003-04-08 | Jinis Biopharmaceuticals Co | Method for producing low cholesterol animal food product and food product therefrom |
KR20020093147A (ko) * | 2002-05-30 | 2002-12-13 | 지니스생명공학 주식회사 | 성인병 예방 및 치료 보조제 |
KR100710500B1 (ko) | 2005-05-18 | 2007-04-24 | 고려대학교 산학협력단 | 홍국균을 이용한 모나콜린 k 생산방법 |
EP2373609B1 (fr) | 2008-12-19 | 2013-10-16 | KRKA, D.D., Novo Mesto | Utilisation de composés amphiphiles pour la cristallisation régulée de statines et d'intermédiaires de statines |
EP2327682A1 (fr) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Utilisation de composés amphiphiles pour la crystallisation controlée de statines et d'intermediaires de statines. |
RO128803A0 (ro) | 2012-10-12 | 2013-09-30 | Ion Gigel Fulga | Compoziţie pentru tratamentul sau prevenirea dislipidemiilor |
CN110331151A (zh) * | 2019-04-11 | 2019-10-15 | 北京工商大学 | 紫色红曲菌mokH基因过表达菌株的构建方法 |
CN111297938A (zh) * | 2020-03-11 | 2020-06-19 | 北京康立生医药技术开发有限公司 | 一种辅助降血脂组合物中洛伐他汀的检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5612114B2 (fr) * | 1974-06-07 | 1981-03-18 | ||
JPS55150898A (en) * | 1979-05-11 | 1980-11-25 | Sankyo Co Ltd | Preparation of a new physiologically active substance mb-530b |
AU535944B2 (en) * | 1979-06-15 | 1984-04-12 | Merck & Co., Inc. | Hypocholestermic fermentation products from aspergillus |
-
1979
- 1979-02-20 JP JP54017856A patent/JPS5925599B2/ja not_active Expired
-
1980
- 1980-02-19 KR KR1019800000654A patent/KR830002801B1/ko active
- 1980-02-19 CA CA345,983A patent/CA1129794A/fr not_active Expired
- 1980-02-19 AU AU55673/80A patent/AU532626B2/en not_active Expired
- 1980-02-19 IE IE321/80A patent/IE49743B1/en not_active IP Right Cessation
- 1980-02-20 DE DE3051175A patent/DE3051175C2/de not_active Expired
- 1980-02-20 NL NL8001041A patent/NL191540C/xx not_active IP Right Cessation
- 1980-02-20 AT AT0092980A patent/AT373915B/de not_active IP Right Cessation
- 1980-02-20 HU HU80397A patent/HU182069B/hu unknown
- 1980-02-20 DK DK73080A patent/DK149095C/da not_active IP Right Cessation
- 1980-02-20 SU SU802887300A patent/SU1158048A3/ru active
- 1980-02-20 DE DE3006216A patent/DE3006216C2/de not_active Expired
- 1980-02-20 NO NO800451A patent/NO153974C/no unknown
- 1980-02-20 FR FR8003662A patent/FR2449685B1/fr not_active Expired
- 1980-02-20 PL PL1980222120A patent/PL124304B1/pl unknown
- 1980-02-20 BE BE0/199476A patent/BE881825A/fr not_active IP Right Cessation
- 1980-02-20 SE SE8001339A patent/SE453301B/sv not_active IP Right Cessation
- 1980-02-20 NZ NZ192919A patent/NZ192919A/en unknown
- 1980-02-20 ZA ZA00800962A patent/ZA80962B/xx unknown
- 1980-02-20 MX MX808652U patent/MX6314E/es unknown
- 1980-02-20 PH PH23668A patent/PH15145A/en unknown
- 1980-02-20 DD DD80219159A patent/DD154494A5/de unknown
- 1980-02-20 ES ES488796A patent/ES8103171A1/es not_active Expired
- 1980-02-20 IT IT67262/80A patent/IT1175260B/it active
- 1980-02-20 FI FI800506A patent/FI66427C/fi not_active IP Right Cessation
- 1980-02-20 CH CH136680A patent/CH645890A5/de not_active IP Right Cessation
- 1980-02-20 GB GB8005748A patent/GB2046737B/en not_active Expired
- 1980-09-12 SU SU802977031A patent/SU969702A1/ru active
-
1984
- 1984-01-24 SG SG67/84A patent/SG6784G/en unknown
-
1989
- 1989-01-18 DK DK021889A patent/DK21889D0/da not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH645890A5 (de) | Monacolin k, seine herstellung und dieses enthaltendes antihypercholesterinaemisches mittel. | |
CH645891A5 (de) | Verfahren zur herstellung von monacolin k. | |
DE68910213T2 (de) | Antibiotikum R106. | |
DE2743654B2 (de) | Anthracyclinglycoside der Gruppe MA 144-, Verfahren zu ihrer Herstellung sowie diese Glycoside enthaltende pharmazeutische Zubereitungen | |
DE3028284C2 (fr) | ||
DE3109335C2 (de) | Ebelacton A und B, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel | |
CH630957A5 (de) | Verfahren zur herstellung von neuen antibiotischen verbindungen auf basis eines bohemsaeurekomplexes. | |
DE68920973T2 (de) | Antibiotika und deren Verfahren zur Herstellung. | |
DE3112566C2 (fr) | ||
DE2849696A1 (de) | Verfahren zur herstellung des antibiotikums c-15003 p-3 | |
DE2537028A1 (de) | Antibioticum, ein verfahren zu seiner herstellung sowie seine verwendung als pflanzenschutzmittel | |
DE2028403C3 (de) | Pepstatin | |
EP0019302A1 (fr) | Composés tétracycliques, procédés pour leur préparation, leur utilisation et compositions pharmaceutiques | |
DE3228306A1 (de) | Verfahren zur herstellung von polyen-antibiotika und eines neuen tetraen-antibiotikums mit wirksamkeit gegen fungi | |
DE2120930A1 (de) | Pepsin-Inhibitor und Verfahren zu dessen Herstellung | |
DE3247175A1 (de) | Dihydro- und tetrahydromonacolin l, ihre metallsalze und alkylester sowie verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
DE2839668A1 (de) | Als antibiotika wirksame saframycine a, b, c, d und e und verfahren zu ihrer herstellung | |
DE2303495C2 (de) | Herstellung von Ergosterin und seinen Estern | |
CH640269A5 (de) | Verfahren zur herstellung des antibiotikums c-15003 p-4. | |
DE69718141T2 (de) | Fungizid | |
DE69214737T2 (de) | Antibiotika NK374186A, NK374186B, NK374186B3 und NK374186C3, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE3881566T2 (de) | Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
AT350716B (de) | Verfahren zur herstellung neuer antibiotika | |
DE2645528C3 (de) | Antibiotisch wirksame Pyrrole [2,1c] -1,4benzdiazepine | |
DE975919C (de) | Verfahren zur Gewinnung eines Mutterkornalkaloidgemisches |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |